Skip to search formSkip to main contentSkip to account menu

yttrium Y 90 DOTA monoclonal antibody HuAFP31

Known as: Yttrium Y-90 Tacatuzumab Tetraxetan, Yttrium Y 90 Tacatuzumab Tetraxetan, Y90 DOTA MOAB HuAFP31 
A radioimmunoconjugate comprised of the humanized monoclonal antibody tacatuzumab, directed against alpha fetoprotein, that is conjugated to the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
http://dx.doi.or 0001-2998/& 2 ment of Nucle ara, Turkey. s reprint reques lear Medicine, 00, Ankara, T oo.com Intra-arterial… 
Review
2014
Review
2014
Abstract Since the conception of the journal Current Radiopharmaceuticals in January 2008, we have been inundated with a variety… 
Review
2014
Review
2014
PURPOSE The purpose of this presentation is to discuss the radiation safety and dosimetric technique used for the therapeutic… 
Review
2012
Review
2012
Radioimmunotherapy (RIT) efficacy has been demonstrated in hematology, in particular in B cell non-Hodgkin lymphoma (NHL). RIT… 
Review
2011
Review
2011
Tc-99m macroaggregated albumin (MAA) hepatic perfusion study and hepatic angiography are routinely performed prior to yttrium-90…